scholarly article | Q13442814 |
P2093 | author name string | Wilhelm Haverkamp | |
Wolfram Doehner | |||
Burkert Pieske | |||
Leif-Hendrik Boldt | |||
Frank R Heinzel | |||
Andrea Stroux | |||
Felix Hohendanner | |||
Florian Blaschke | |||
Philipp Lacour | |||
Abdul Shokor Parwani | |||
Franziska Schuessler | |||
Carsten Tschoepe | |||
Daniel Armando Morris | |||
Phi Long Dang | |||
P2860 | cites work | Impact of iron deficiency on long-term clinical outcomes of hospitalized patients with heart failure | Q88179691 |
Impact of Iron Deficiency on Response to and Remodeling After Cardiac Resynchronization Therapy | Q88624609 | ||
Iron deficiency and risk of early readmission following a hospitalization for acute heart failure | Q89091635 | ||
Nutritional anaemias. Report of a WHO scientific group | Q93781755 | ||
2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Associ | Q33162947 | ||
Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency†. | Q34041875 | ||
Modulation of mitochondrial proteome and improved mitochondrial function by biventricular pacing of dyssynchronous failing hearts | Q34066942 | ||
The effect of cardiac resynchronization on morbidity and mortality in heart failure | Q34400885 | ||
Cardiac resynchronization in chronic heart failure | Q34524008 | ||
Effects of ferric carboxymaltose on hospitalisations and mortality rates in iron-deficient heart failure patients: an individual patient data meta-analysis | Q36354815 | ||
Redox regulation of mitochondrial ATP synthase: implications for cardiac resynchronization therapy. | Q36406423 | ||
Iron deficiency and heart failure: diagnostic dilemmas and therapeutic perspectives | Q36682182 | ||
The role of iron in mitochondrial function | Q37307193 | ||
Noninvasive imaging in cardiac resynchronization therapy--part 1: selection of patients | Q37307892 | ||
An individual patient meta-analysis of five randomized trials assessing the effects of cardiac resynchronization therapy on morbidity and mortality in patients with symptomatic heart failure | Q37374291 | ||
Molecular changes in myocardium in the course of anemia or iron deficiency | Q37772635 | ||
Non-responders to cardiac resynchronization therapy: the magnitude of the problem and the issues | Q37843186 | ||
Cardiac resynchronization therapy: state-of-the-art of current applications, guidelines, ongoing trials, and areas of controversy | Q38166257 | ||
Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. | Q38364873 | ||
Effect of Ferric Carboxymaltose on Exercise Capacity in Patients with Chronic Heart Failure and Iron Deficiency | Q38374099 | ||
Effectiveness of Cardiac Resynchronization Therapy by QRS Morphology in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT). | Q38494075 | ||
Ferric carboxymaltose in patients with heart failure and iron deficiency | Q43240282 | ||
Cardiac-Resynchronization Therapy for Mild-to-Moderate Heart Failure | Q43489268 | ||
A meta-analysis of left ventricular dyssynchrony assessment and prediction of response to cardiac resynchronization therapy by three-dimensional echocardiography | Q44963867 | ||
Iron deficiency in chronic heart failure: an international pooled analysis | Q46257022 | ||
Dietary iron deficiency induces ventricular dilation, mitochondrial ultrastructural aberrations and cytochrome c release: involvement of nitric oxide synthase and protein tyrosine nitration | Q46475649 | ||
Myocardial iron content and mitochondrial function in human heart failure: a direct tissue analysis. | Q46487624 | ||
Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial | Q46810797 | ||
Iron deficiency and health-related quality of life in chronic heart failure: results from a multicenter European study | Q48078246 | ||
Iron deficiency: an ominous sign in patients with systolic chronic heart failure | Q48155909 | ||
Iron deficiency status irrespective of anemia: a predictor of unfavorable outcome in chronic heart failure patients | Q48718639 | ||
Super-response to cardiac resynchronization therapy reduces appropriate implantable cardioverter defibrillator therapy | Q50089231 | ||
Definitions for a common standard for 2D speckle tracking echocardiography: consensus document of the EACVI/ASE/Industry Task Force to standardize deformation imaging. | Q50603533 | ||
Etiology of anemia in patients with advanced heart failure. | Q50711526 | ||
Iron deficiency in a multi-ethnic Asian population with and without heart failure: prevalence, clinical correlates, functional significance and prognosis | Q51114270 | ||
Iron deficiency in heart failure: Impact on response to cardiac resynchronization therapy. | Q51592442 | ||
Comparison of myocardial deformation and velocity dyssynchrony for identification of responders to cardiac resynchronization therapy. | Q53365788 | ||
Survival with cardiac-resynchronization therapy in mild heart failure. | Q53587733 | ||
Iron Deficiency Predicts Impaired Exercise Capacity in Patients With Systolic Chronic Heart Failure | Q57911477 | ||
Mechanism of harm from left bundle branch block | Q58564135 | ||
Clinical versus echocardiographic parameters to assess response to cardiac resynchronization therapy | Q82404923 | ||
Insights from a cardiac resynchronization optimization clinic as part of a heart failure disease management program | Q83397540 | ||
Incidence and predictors of right ventricular pacing-induced cardiomyopathy | Q88011294 | ||
P577 | publication date | 2020-03-18 | |
P1433 | published in | ESC Heart Failure | Q27727376 |
P1476 | title | The effect of iron deficiency on cardiac resynchronization therapy: results from the RIDE-CRT Study |